Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment leads ...

Learn the dangerous waist warning signs that predict serious health problems. Discover what happens when you ignore these ...

whereas the DKK1-treated mouse group exhibited significantly reduced fibrosis. Conclusion: The Wnt signaling pathway plays a key role in the development of hepatic fibrosis associated with AE ...

Galecto is a clinical-stage biopharmaceutical company committed to realizing the promise of novel treatments for cancer and liver diseases ... cancer and fibrosis signaling pathways, including ...

The Company's pipeline consists of first-in-class small molecule drug candidates that target cancer and fibrosis signaling pathways, including (i) an orally active galectin-3 inhibitor (GB1211) for ...

Semaglutide significantly improved liver fibrosis and steatohepatitis resolution in MASH patients over 72 weeks compared to placebo. The study involved 800 patients receiving semaglutide and 400 ...

In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of patients and reduced liver fibrosis ... hepatic and metabolic pathways. Further research is ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic dysfunction-associated steatotic liver disease, or MASLD. The company said ...